Skip to content
Screener

Tango Therapeutics TNGX Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$207M+6.7%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$350K+13.6%
Erasca, Inc. logo
Erasca, Inc.ERAS
$5.25M+9.6%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$1.49M-10.2%
Immunome logo
ImmunomeIMNM
$152K
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$2.43M+3.5%

Other financials

Income statement

See full
Revenue--100%
Operating income-$48.8M-14.7%
Net income-$45.5M-14.1%
EPS (diluted)-$0.32+11.1%

Balance sheet

See full
Cash & equivalents$160.0M+162%
Total debt$32.8M-11.3%
Total equity$391.5M+135%
Total assets$435.8M+58.9%

Cash flow

See full
Operating cash flow-$44.4M-6.4%
CapEx-$2.0K-104%
Free cash flow-$44.4M-6.3%

Valuation

See full
Market cap$4.41B+518%
Enterprise value$4.28B+506%
P/S77.3×+48.0×

Profitability

See full
Operating margin-206.2%-61.0pp
Net margin-188.2%-55.4pp
FCF margin-250.1%-49.4pp

Returns & leverage

See full
Return on equity-38.4%-10.5pp
Debt / equity0.1×-0.1×
Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Tango Therapeutics’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-221656
Line itemMarch 31, 2026December 31, 2025
Current liabilities:
Accounts payable$2,430$1,182
Accrued expenses and other current liabilities9,06817,759
Operating lease liabilities2,8322,738
Total current liabilities14,33021,679
Operating lease liabilities, net of current portion29,95630,832
Total liabilities44,28652,511
Commitments and contingencies (Note 7)

Item 1. Financial Statements.

FAQ

What is Tango Therapeutics's operating lease liabilities (current)?
Tango Therapeutics (TNGX) reported operating lease liabilities (current) of $2.83M in Q1 2026.
How has Tango Therapeutics's operating lease liabilities (current) changed year-over-year?
Tango Therapeutics's operating lease liabilities (current) increased by 0.3% year-over-year, from $2.82M to $2.83M.
What is the long-term trend for Tango Therapeutics's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Tango Therapeutics's operating lease liabilities (current) has grown at a 23.3% compound annual growth rate (CAGR), from $959K to $2.74M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Tango Therapeutics's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude